DE3688051D1 - Immunochemisches reagenz. - Google Patents

Immunochemisches reagenz.

Info

Publication number
DE3688051D1
DE3688051D1 DE8686202213T DE3688051T DE3688051D1 DE 3688051 D1 DE3688051 D1 DE 3688051D1 DE 8686202213 T DE8686202213 T DE 8686202213T DE 3688051 T DE3688051 T DE 3688051T DE 3688051 D1 DE3688051 D1 DE 3688051D1
Authority
DE
Germany
Prior art keywords
immunochemical reagent
immunochemical
reagent
htlv
immunoassays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686202213T
Other languages
English (en)
Other versions
DE3688051T2 (de
Inventor
Michael L Berman
Sylvia A Crush
Flossie Wong-Staal
Robert C Gallo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of DE3688051D1 publication Critical patent/DE3688051D1/de
Publication of DE3688051T2 publication Critical patent/DE3688051T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
DE8686202213T 1985-12-17 1986-12-08 Immunochemisches reagenz. Expired - Fee Related DE3688051T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80987285A 1985-12-17 1985-12-17
US86190086A 1986-05-08 1986-05-08
US88729486A 1986-07-18 1986-07-18
US92757786A 1986-11-14 1986-11-14

Publications (2)

Publication Number Publication Date
DE3688051D1 true DE3688051D1 (de) 1993-04-22
DE3688051T2 DE3688051T2 (de) 1993-06-24

Family

ID=27505837

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686202213T Expired - Fee Related DE3688051T2 (de) 1985-12-17 1986-12-08 Immunochemisches reagenz.

Country Status (8)

Country Link
EP (1) EP0227169B1 (de)
JP (1) JP2587414B2 (de)
AT (1) ATE87103T1 (de)
DE (1) DE3688051T2 (de)
DK (1) DK610786A (de)
ES (1) ES2054616T3 (de)
FI (1) FI91282C (de)
NO (1) NO171477C (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
DE3722272A1 (de) * 1986-07-08 1988-01-21 Bio Rad Laboratories Differenzierung des krankheitszustandes bei aids-antikoerpertests
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US4861707A (en) * 1987-02-02 1989-08-29 E. I. Du Pont De Nemours And Company Human immunodeficiency virus antigen
US5141867A (en) * 1987-02-02 1992-08-25 E. I. Du Pont De Nemours And Company Nucleotide sequence encoding a human immunodeficiency virus antigen
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
EP0316495A1 (de) * 1987-11-19 1989-05-24 Iaf Biochem International Inc. Zum Nachweis von AIDS-verwandten Antikörpern in menschlichem Serum dienende synthetische Peptide
US5204259A (en) * 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
CU22222A1 (es) * 1989-08-03 1995-01-31 Cigb Procedimiento para la expresion de proteinas heterologicas producidas de forma fusionada en escherichia coli, su uso, vectores de expresion y cepas recombinantes
US6248574B1 (en) * 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
US5876724A (en) * 1990-03-19 1999-03-02 Institut Pasteur Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
EP0572737B1 (de) * 1992-06-04 2001-02-28 The Research Foundation For Microbial Diseases Of Osaka University Gag-Env Fusion-Antigen aus HIV
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
WO1997014436A1 (en) * 1995-10-20 1997-04-24 Duke University Synthetic vaccine for protection against human immunodeficiency virus infection
US6093400A (en) * 1996-08-09 2000-07-25 Cel Sci Corporation Modified HGP-30 peptides, conjugates, compositions and methods of use
CN1233187A (zh) 1996-08-09 1999-10-27 病毒技术公司 HIVp－17肽片段、含有该片段的组合物及其制造和使用方法
US20100111990A1 (en) * 2007-03-23 2010-05-06 Sanofi Pasteur Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
EP0220234B1 (de) * 1985-04-08 1994-08-03 Genetic Systems Corporation EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND
DE3674555D1 (de) * 1985-12-20 1990-10-31 Abbott Lab Immuntest fuer antikoerper gegen htlv-iii.
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein

Also Published As

Publication number Publication date
FI91282C (fi) 1994-06-10
FI91282B (fi) 1994-02-28
NO865094L (no) 1987-06-18
FI865123A (fi) 1987-06-18
JPS62240863A (ja) 1987-10-21
AU6651986A (en) 1987-07-02
DE3688051T2 (de) 1993-06-24
ES2054616T3 (es) 1994-08-16
DK610786A (da) 1987-06-18
JP2587414B2 (ja) 1997-03-05
EP0227169B1 (de) 1993-03-17
ATE87103T1 (de) 1993-04-15
DK610786D0 (da) 1986-12-17
NO171477B (no) 1992-12-07
EP0227169A2 (de) 1987-07-01
NO171477C (no) 1993-03-17
EP0227169A3 (en) 1989-07-12
FI865123A0 (fi) 1986-12-16
NO865094D0 (no) 1986-12-16
AU612315B2 (en) 1991-07-11

Similar Documents

Publication Publication Date Title
ES2054616T3 (es) Reactivo inmunoquimico.
EP0231914A3 (en) Htlv-iii envelope peptides
DE3679877D1 (de) Immunologisches testverfahren fuer htlv-iii-antigene.
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
EP0345462A3 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde
ES463124A1 (es) Procedimiento de obtencion de un complejo antigeno-proteina multivalente para bloquear reacciones alergicas.
DE3579009D1 (de) Adult-t-zell-leukemiavirus-antigenpolypeptid.
AU590203B2 (en) Immunoassay for detection of common determinant antibody to hepatitis B
NO874453L (no) Fremgangsmaate til bestemmelse av anti-hiv, middel dertil og dets anvendelse i fremgangsmaaten.
ES8507100A1 (es) Un procedimiento para preparar oligopeptidos dimeros
PT90369A (pt) Processo para a preparacao de anticorpos monoclonais para a determinacao imunologica selectiva de peptido do procolagenio intacto (tipo iii) e de procolagenio (tipo iii) em fluidos corporais e processo de determinacao usando esses anticorpos
DE3688204D1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
DE3751078D1 (de) Quartz-Oszillator mit breitem Ziehbereich.
NZ215143A (en) Immunoassay and test kit for aids
FI882019A0 (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
ATE28937T1 (de) Immunotest fuer kohlehydrat-antigen-determinant.
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8339 Ceased/non-payment of the annual fee